>Positive impact of Q1 2024 on estimates - Following an excellent Q1 2024, we are marginally raising our forecasts as of 2025 (except 2024 due to a non-cash impact of the derivative contract for € 8bn):We factor in the cloud contract with the government agencies (ITZBund) that enable a ramp-up in revenues as of 2025 (revenues forecast at over € 20m per year over 5 years). We now expect 17% over CAGR growth in 2023-2026 vs 13% previously.We are slightly rais...
>Impact positif du T1 2024 sur les estimations - A la suite d’un excellent T1 2024, nous relevons légèrement nos prévisions à partir de 2025 (sauf 2024 en raison d’un impact non-cash de contrat de dérivés de 8 Md€):Nous intégrons le contrat de cloud avec les agences du gouvernement (ITZBund) qui permettent une accélération du CA dés 2025 (CA attendu à plus de 20 M€ par an sur 5 ans). Nous prévoyons désormais 17% de croissance TMVA sur 2023-2026 vs 13% précédemmen...
Unifiedpost is a niche SaaS player in the e-invoicing and procurement channel space. Regulatory headwinds mean this market is ripe for growth, which should benefit Unifiedpost. Due to some unsuccessful past M&A, the company is in a challenging financial position today. However, it has recently embarked on a divestment path, aiming to streamline the business and improve its fundamentals. We like the new direction, however prefer to take a wait-and-see approach. - ...
Unifiedpost is a niche SaaS player in the e-invoicing and procurement channel space. Regulatory headwinds mean this market is ripe for growth, which should benefit Unifiedpost. Due to some unsuccessful past M&A, the company is in a challenging financial position today. However, it has recently embarked on a divestment path, aiming to streamline the business and improve its fundamentals. We like the new direction, however prefer to take a wait-and-see approach. - ...
>Underlying growth at 3.9%, high margin - Synlab reported € 682.4m in Q1 revenues, down 2.8% (+3.9% underlying growth). Adjusted EBITDA came in at € 123.1m and adjusted operating profit at € 64.8m.Adjusted net debt stood at € 1,249m (reported net debt € 1,285m) vs € 1,582m at the end of Q1 2023 (and € 1.3bn at end-2023). Reported financial leverage stands at 2.75x (vs 2.9x at end-2023).Management reiterated its 2024 guidance, namely 4% organic growth (around...
>Croissance underlying à 3,9% - Bon niveau de marge - Synlab publie un CA T1 à 682,4 M€, soit -2,8% (+3,9% underlying growth). L’EBITDA ajusté ressort à 123,1 M€ et le ROP ajusté, à 64,8 M€.La dette nette ajustée atteint 1 249 M€ (DN publiée 1 285 M€) vs 1 582 M€ fin T1 2023 (et 1 300 M€ fin 2023). Le levier financier publié ressort à 2,75x (vs 2,9x fin 2023).Le management réitère sa guidance 2024 ie. une croissance organique de 4% (env. 2 700 M€), une marge...
>Ex disposals, Q1 results roughly in-line with expectations - Revenues in 24Q1 have fallen to $ 240.4m, down from $ 340m in 23Q1. Net revenues (after voyage expense) in 24Q1 have fallen to $ 203.5m (AAOB $ 197.9m) from $ 305.1m in 23Q1.EBITDA is reported at $ 550.5m but excluding disposal gain of $ 407.6m amounts to $ 142.9m (BB consensus $ 150m), down from $ 258.5m in 23Q1Net profit in 24Q1 has jumped to $ 495.0m (AAOB $ 492.6m) primarily thanks to the $ 40...
AB InBev: Busy BEES. Ahold Delhaize: Small beat, comforting confirmation of 2024 guidance. AMG: 1Q24 better than expected, FY guidance intact, strategic projects on schedule. Bekaert: Soft start to the year with 7% sales miss, FY guidance maintained. Euronav: Transformation at full speed. Marel: Another lacklustre quarter. Montea: 2025 guidance raised, valuations moving into positive territory. SBM Offshore: In-line Q1 trading update. Sif Group: Preview - normal quarter e...
EQS-News: IONOS Group SE / Schlagwort(e): Quartals-/Zwischenmitteilung/Quartals-/Zwischenmitteilung IONOS Group SE mit Q1 2024 Ergebnissen und Bestätigung der Prognose für 2024 08.05.2024 / 07:30 CET/CEST Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. + 200.000 Kunden auf 6,26 Mio. (Q1 2023: 6,06 Mio. Kunden) + 5,4 % Umsatz auf 373,0 Mio. € (Q1 2023: 353,8 Mio. €) + 22,7 % bereinigtes EBITDA auf 105,3 Mio. € (Q1 2023: 86,2 Mio. €) Prognose 2024 bestätigt Karlsruhe / Berlin, 8. Mai 2024. Die IONOS Group SE, der führende europäische Digitali...
EQS-News: IONOS Group SE / Key word(s): Quarterly / Interim Statement/Quarterly / Interim Statement IONOS Group SE with Q1 2024 results and confirmation of guidance for 2024 08.05.2024 / 07:30 CET/CEST The issuer is solely responsible for the content of this announcement. + 200,000 customers to 6.26 million (Q1 2023: 6.06 million customers) + 5.4% sales to € 373.0 million (Q1 2023: € 353.8 million) + 22.7% adjusted EBITDA to € 105.3 million (Q1 2023: € 86.2 million) Guidance for 2024 confirmed Karlsruhe / Berlin, 08 May 2024: IONOS Group SE, the leading European digita...
EQS-News: SYNLAB AG / Key word(s): Quarter Results SYNLAB delivers strong performance in Q1 2024 08.05.2024 / 07:00 CET/CEST The issuer is solely responsible for the content of this announcement. SYNLAB delivers strong performance in Q1 2024 Revenue at €682 million Strong underlying organic growth at 3.9% (Q1 2023: 10.0%); 5.2% adjusted for working days Adjusted EBITDA at €123 million (increased by 4% compared to Q1 2023) Strong Adjusted EBITDA margin at 18.0% (Q1 2023: 16.9%), at the upper end of the guided range for FY 2024 of 17-18% €8 million of SALIX savings ...
EQS-News: SYNLAB AG / Schlagwort(e): Quartalsergebnis SYNLAB erzielt starke Leistung im Q1 2024 08.05.2024 / 07:00 CET/CEST Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. SYNLAB erzielt starke Leistung im Q1 2024 Umsatzerlöse von 682 Mio. € Starkes zugrunde liegendes organisches Wachstum von 3,9 % (Q1 2023: 10,0 %) bzw. 5,2 % (arbeitstagebereinigt) Bereinigtes EBITDA von 123 Mio. € (Anstieg um 4 % gegenüber Q1 2023) Starke AEBITDA-Marge von 18,0 % (Q1 2023: 16,9 %) am oberen Ende der Prognose für das Geschäftsjahr 2024 von 17 - 18 % S...
PARIS--(BUSINESS WIRE)-- Regulatory News: CARMAT (FR0010907956, ALCAR, éligible PEA-PME), concepteur et développeur du projet de cœur artificiel total le plus avancé au monde, visant à offrir une alternative thérapeutique aux malades souffrant d’insuffisance cardiaque biventriculaire avancée, informe ses actionnaires et l’ensemble de la communauté financière que l’assemblée générale mixte de la Société se tiendra le jeudi 30 mai 2024 à 10 heures, au Best Western Plus Paris Velizy, 1 Place de l’Europe, 78140 Velizy Villacoublay. A défaut d’assister personnellement à cette assemblée, les act...
PARIS--(BUSINESS WIRE)-- Regulatory News: CARMAT (FR0010907956, ALCAR, éligible PEA-PME), concepteur et développeur du cœur artificiel total le plus avancé au monde (la « Société » ou « CARMAT »), visant à offrir une alternative thérapeutique aux malades souffrant d’insuffisance cardiaque biventriculaire avancée, fait aujourd’hui un point sur l’étude EFICAS et réitère sa confiance dans ses perspectives 2024. Stéphane Piat, Directeur général de CARMAT, déclare : « Je suis très satisfait de la progression de l’étude EFICAS, tant sur le rythme d’inclusions que sur les résultats observés à dat...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.